[go: up one dir, main page]

MXPA02012091A - Un metodo de tratamiento de esclerosis lateral amiotrofica con una proteina que se puede extraer de organos de mamifero. - Google Patents

Un metodo de tratamiento de esclerosis lateral amiotrofica con una proteina que se puede extraer de organos de mamifero.

Info

Publication number
MXPA02012091A
MXPA02012091A MXPA02012091A MXPA02012091A MXPA02012091A MX PA02012091 A MXPA02012091 A MX PA02012091A MX PA02012091 A MXPA02012091 A MX PA02012091A MX PA02012091 A MXPA02012091 A MX PA02012091A MX PA02012091 A MXPA02012091 A MX PA02012091A
Authority
MX
Mexico
Prior art keywords
treatment
lateral sclerosis
amyotrophic lateral
mammalian organs
protein extractable
Prior art date
Application number
MXPA02012091A
Other languages
English (en)
Inventor
Alberto Panerai
Original Assignee
Rakepoll Holding B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rakepoll Holding B V filed Critical Rakepoll Holding B V
Publication of MXPA02012091A publication Critical patent/MXPA02012091A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Neurosurgery (AREA)
  • Cell Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Un metodo de tratamiento de pacientes afectados por esclerosis lateral amiotrofica comprende la administracion de una cantidad efectiva de una proteina 14 kDa que se puede extraer de organos de mamifero, particularmente higado de mamifero.
MXPA02012091A 2000-06-08 2001-06-04 Un metodo de tratamiento de esclerosis lateral amiotrofica con una proteina que se puede extraer de organos de mamifero. MXPA02012091A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21000300P 2000-06-08 2000-06-08
PCT/EP2001/006336 WO2001093888A2 (en) 2000-06-08 2001-06-04 A method of treatment of amyotrophic lateral sclerosis with a protein extractable from mammalian organs

Publications (1)

Publication Number Publication Date
MXPA02012091A true MXPA02012091A (es) 2004-08-19

Family

ID=22781221

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02012091A MXPA02012091A (es) 2000-06-08 2001-06-04 Un metodo de tratamiento de esclerosis lateral amiotrofica con una proteina que se puede extraer de organos de mamifero.

Country Status (7)

Country Link
US (1) US6855694B2 (es)
EP (1) EP1286683A2 (es)
JP (1) JP2003535139A (es)
AU (1) AU2001278436A1 (es)
CA (1) CA2411428A1 (es)
MX (1) MXPA02012091A (es)
WO (1) WO2001093888A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070049630A1 (en) * 2005-08-24 2007-03-01 Allergan, Inc. Method of using ryanodine receptor antagonists to treat amyotrophic lateral sclerosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1244879B (it) 1990-12-11 1994-09-12 Alberto Bartorelli Estratti da tessuti animali, utili in terapia e in diagnostica.
IL129024A0 (en) * 1996-09-18 2000-02-17 Zetesis Spa Use of proteins as agent against autoimmune diseases
IT1290828B1 (it) * 1997-03-25 1998-12-11 Zetesis Spa Uso di proteine estraibili da organi animali per la preparazione di medicamenti per il trattamento di condizioni patologiche

Also Published As

Publication number Publication date
AU2001278436A1 (en) 2001-12-17
US20030162705A1 (en) 2003-08-28
US6855694B2 (en) 2005-02-15
WO2001093888A3 (en) 2002-11-07
JP2003535139A (ja) 2003-11-25
CA2411428A1 (en) 2001-12-13
WO2001093888A2 (en) 2001-12-13
EP1286683A2 (en) 2003-03-05

Similar Documents

Publication Publication Date Title
DE59914996D1 (en) Heterocyclisch substituierte amide als calpainhemmer
IL231675A (en) Concentrated protein compositions with reduced viscosity
DE69905368D1 (en) Oxydiertes thymosin beta 4
PT1349856E (pt) Compostos de isoindolina-1-ona activadores da glicocinase
MXPA03003870A (es) Terapia de combinacion que comprende agentes antidiabeticos y anticonvulsionantes.
MXPA02001911A (es) Anticuerpos ctla-4 humanos y sus usos.
BG105784A (en) Triazole compounds with dopamine-d3-receptor affinity
WO2002006301A3 (en) Peptides with antioxidant and antimicrobial properties
BR0208727A (pt) Eritropoietina melhorando a toxicidade in vivo induzida por quimioterapia
TR199901104T2 (xx) Farmas�tik bile�ikler.
ITTO940748A0 (it) Condotto protesico particolarmente per il trattamento di patologie cardiovascolari.
MXPA03003741A (es) Metodos y composiciones para el tratamiento de enfermedades oftalmicas.
MY139368A (en) Novel cyclohexyl sulphones
ITBO990309A0 (it) Macchina per la realizzazione di sacchetti - filtro di prodotti da inf usione .
EP1178796A4 (en) AMINOIMIDAZOLE CARBOXAMIDE SALTS USEFUL IN THE PREVENTION AND TREATMENT OF LIVER DISEASE
EA200100133A1 (ru) Оксазолидиноны для лечения инфекционных болезней глаз
MXPA02012089A (es) Metodo de tratamiento de la enfermedad de alzheimer con una proteina extraible de organos mamiferos.
WO2002043757A3 (de) Arzneimittel zur vermeidung oder behandlung von durch humanen papillomavirus-typ 18-hervorgerufenem tumor
AUPP823999A0 (en) A treatment
MXPA02012091A (es) Un metodo de tratamiento de esclerosis lateral amiotrofica con una proteina que se puede extraer de organos de mamifero.
EP1121932A4 (en) MEDICINE FOR EYE DISEASES
WO2003059387A3 (en) Combination comprising anti-cd52 antibodies and other therapeutic agents for treatment for multiple sclerosis
MXPA02012090A (es) Un metodo de tratamiento de corea de huntington con una proteina que se puede extraer de organos de mamifero.
MXPA02012092A (es) Metodo de tratamiento de la enfermedad de parkinson con una proteina extraible de organos.
PL355113A1 (en) Novel fusidic acid derivatives